Researchers at the National University of Singapore (NUS) and the Temasek Life Sciences Laboratory have developed an oral vaccine for fish that protects against the nervous necrosis virus (NNV). By encapsulating virus-like particles within Lactococcus lactis bacteria, the vaccine can be mixed directly into fish feed, offering a practical, labour efficient and cost-effective alternative to … Read more
The Silent Threat: Why Ketone Monitoring is the Next Frontier in Diabetes Care For millions living with diabetes, the daily routine revolves around blood glucose numbers. While continuous glucose monitors (CGMs) have revolutionized how we manage the condition, a dangerous, often silent complication remains a leading cause of emergency hospitalizations: Diabetic Ketoacidosis (DKA). Recent data … Read more
Beyond Appetite Suppression: The New Frontier of Metabolic Engineering For years, the gold standard for weight management has been the “incretin” revolution. Drugs like semaglutide have dominated the conversation by curbing appetite, but they have brought a troubling side effect: the loss of lean muscle mass. As the medical community looks toward the next generation … Read more
The Future of Kidney Care: Beyond Traditional Metrics For decades, physicians have relied on two primary metrics to assess kidney health: albuminuria (protein in the urine) and eGFR (estimated glomerular filtration rate). While these tools remain essential, they often act as “lagging indicators,” signaling damage that has already occurred. The medical community is now shifting … Read more
The Shift Toward Affordable Metabolic Health: The ‘Generic Effect’ The arrival of generic semaglutide in the Canadian market marks a pivotal turning point in how we approach metabolic health. For years, GLP-1 receptor agonists like Ozempic have been viewed as “miracle drugs,” but their high cost and limited availability created a barrier between the treatment … Read more
Ascletis Pharma Presents Promising Data for Novel Obesity Treatments at ADA 2026 Ascletis Pharma Inc. (HKEX: 1672) is set to present compelling preclinical and clinical data at the American Diabetes Association’s (ADA) 2026 Scientific Sessions, taking place June 5–8 in Recent Orleans, Louisiana. The presentations spotlight the company’s innovative pipeline of oral little molecule therapeutics … Read more
Why Non‑Injectable Peptide Delivery Is Gaining Traction Therapeutic peptides have long been hampered by the need for injections, which limit patient compliance and increase clinic overhead. A new class of oral dissolving strips is turning that paradigm on its head by delivering peptides directly through the oral mucosa. The result is higher bioavailability, painless administration, … Read more
Precision Oncology: A New Era of Cancer Treatment is Dawning The recent partnership between Indivumed and the Wilmot Cancer Institute at the University of Rochester Medical Center (URMC) signals a pivotal moment in the fight against cancer. This collaboration isn’t just another research agreement; it’s a blueprint for the future of precision oncology – a … Read more
Big Law’s Health Care Shake-Up: What’s Next for Managed Care? The legal landscape of the healthcare industry is constantly evolving, and recent moves by major law firms signal significant shifts. The strategic combination of Crowell & Moring with a team of experienced healthcare litigation partners, including trial attorney Martin J. Bishop, is a prime example. … Read more
Hope on the Horizon: A Deep Dive into EBVALLO® and the Future of Immunotherapy for Post-Transplant Lymphoproliferative Disease The announcement of EBVALLO® (tabelecleucel) in the French Journal Officiel on July 4, 2025, marks a significant step forward in the treatment of post-transplant lymphoproliferative disease (PTLD), particularly for patients with Epstein-Barr virus (EBV) positive cases. As … Read more